Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : BC-N102
Catalog No.: PC-72139Not For Human Use, Lab Use Only.
BC-N102 is a first-in-class novel small molecule inhibitor for targeting oncogenic and hormonal signaling in ER-positive breast cancer.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BC-N102 is a first-in-class novel small molecule inhibitor for targeting oncogenic and hormonal signaling in ER-positive breast cancer.
BC-N102 exhibits anticancer activity against breast cancer cell lines via interfering with cell cycle regulatory proteins and hormonal receptors signaling in vitro (IC50=0.04-10 uM), no significant activities against a normal breast cell line.
BC-N102 exhibits potent antitumor activity at tolerated doses in an ER+ human xenograft breast cancer model.
BC-N102 induces arrest of the cell cycle at G0/G1 phase, downregulates the expression of CDK2 and CDK4 independent of the ER in breast cancer cell lines.
| M.Wt | 340.825 | |
| Formula | C18H13ClN2OS | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Bashir Lawal, et al. Int J Biol Sci. 2021 Jul 25;17(12):3224-3238.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
